Harmanjit Singh

About

Harmanjit Singh currently works at Department of Pharmacology, Government Medical College and Hospital, Chandigarh as faculty member. He has almost 10 years of post MD experience in teaching and research. He also worked at the Department of Pharmacology, All India Institute of Medical Sciences as a DM Clinical Pharmacology Resident . His research areas include, pharmacological and clinical aspects of Diabetology, Dyslipidemias and related disorders, Drug safety and Pharmacovigilance, systematic reviews and meta-analysis. He has around 50 publications to his credit and he is a peer reviewer of many reputed journals including BMJ Open, Frontiers in Pharmacology, Molecular Biology Reports, Journal of Postgraduate Medicine, Expert Review of Anti-infective Therapy and others.

Employment

• Government Medical College and Hospital Faculty
  2017 - Present
• All India Institute of Medical Sciences DM. Clinical Pharmacology Resident
  2013 - 2016
• Postgraduate Institute of Medical Education and Research, Chandigarh Senior Resident
  2012 - 2013

Education

• All-India Institute of Medical Sciences DM. Clinical Pharmacology
  2013 - 2016
• Government Medical College MD
  2009 - 2012
• Government Medical College, Amritsar MBBS
  2001 - 2006

Projects & Funding

Projects & funding information is unavailable.

Publications (36)

• Alternate-day add-on therapy with dapagliflozin in patients with type 2 diabetes mellitus: potential benefits and concerns
  Expert Review of Clinical Pharmacology 2022 DOI: 10.1080/17512433.2022.2053111
  +Save
• Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection?
  Expert Review of Clinical Pharmacology 2021 DOI: 10.1080/17512433.2021.1888714
  +Save
• Tafenoquine for Plasmodium vivax malaria: Concerns regarding efficacy & safety
  Indian Journal of Medical Research 2021 DOI: 10.4103/ijmr.IJMR_1167_19
  +Save
• Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective
  International Journal of Risk and Safety in Medicine 2021 DOI: 10.3233/JRS-200060
  +Save
• Potential role of dexamphetamine in the treatment of non-alcoholic fatty liver disease: Hopes and pitfalls
  European Endocrinology 2021 DOI: 10.17925/EE.2021.17.1.33
  +Save
• Pharmacotherapy of schizophrenia: immunological aspects and potential role of immunotherapy
  Expert Review of Neurotherapeutics 2021 DOI: 10.1080/14737175.2021.1994857
  +Save
• Minocycline for the management of multiple sclerosis: repositioning potential, opportunities, and challenges
  Expert Review of Neurotherapeutics 2021 DOI: 10.1080/14737175.2020.1838276
  +Save
• Hydroxychloroquine for the treatment and prophylaxis of COVID-19: The journey so far and the road ahead
  European Journal of Pharmacology 2021 DOI: 10.1016/j.ejphar.2020.173717
  +Save
• Combining hydroxychloroquine and minocycline: potential role in moderate to severe COVID-19 infection
  Expert Review of Clinical Pharmacology 2020 DOI: 10.1080/17512433.2020.1832889
  +Save
• Relationship between statin-associated muscle symptoms, serum Vitamin D and low-density lipoprotein cholesterol - A cross-sectional study
  European Endocrinology 2020 DOI: 10.17925/ee.2020.16.2.137
  +Save